199 related articles for article (PubMed ID: 12894850)
21. X-linked lymphoproliferative disease: a progressive immunodeficiency.
Morra M; Howie D; Grande MS; Sayos J; Wang N; Wu C; Engel P; Terhorst C
Annu Rev Immunol; 2001; 19():657-82. PubMed ID: 11244050
[TBL] [Abstract][Full Text] [Related]
22. Skin lesions in a boy with X-linked lymphoproliferative disorder: comparison of 5 SH2D1A deletion cases.
Mejstríková E; Janda A; Hrusák O; Bucková H; Vlcková M; Hancárová M; Freiberger T; Ravcuková B; Vesely K; Fajkusová L; Kopecková L; Sumerauer D; Kabícková E; Sedivá A; Stary J; Sedlácek Z
Pediatrics; 2012 Feb; 129(2):e523-8. PubMed ID: 22271700
[TBL] [Abstract][Full Text] [Related]
23. [Genetic and proteinic analysis of a Chinese boy with X-linked lymphoproliferative disease and his maternal relatives].
Yang X; Wang J; An YF; Kanegane H; Miyawaki T; Zhao XD
Zhonghua Er Ke Za Zhi; 2011 Jun; 49(6):416-20. PubMed ID: 21924052
[TBL] [Abstract][Full Text] [Related]
24. Novel Mutations in SH2D1A Gene in X-linked Lymphoproliferative Syndrome, Diagnosed After B-Cell Non-Hodgkin Lymphoma.
Sharapova SO; Fedorova AS; Pashchenko OE; Vahliarskaya SS; Guryanova IE; Migas AA; Kondratenko IV; Aleinikova OV
J Pediatr Hematol Oncol; 2017 May; 39(4):e203-e206. PubMed ID: 28267077
[TBL] [Abstract][Full Text] [Related]
25. Variable clinical phenotypes of X-linked lymphoproliferative syndrome in China: Report of five cases with three novel mutations and review of the literature.
Jin YY; Zhou W; Tian ZQ; Chen TX
Hum Immunol; 2016 Aug; 77(8):658-666. PubMed ID: 27288720
[TBL] [Abstract][Full Text] [Related]
26. Genetic screening of male patients with primary hypogammaglobulinemia can guide diagnosis and clinical management.
Vince N; Mouillot G; Malphettes M; Limou S; Boutboul D; Guignet A; Bertrand V; Pellet P; Gourraud PA; Debré P; Oksenhendler E; Théodorou I; Fieschi C;
Hum Immunol; 2018 Jul; 79(7):571-577. PubMed ID: 29709555
[TBL] [Abstract][Full Text] [Related]
27. The X-linked lymphoproliferative syndrome gene product SH2D1A associates with p62dok (Dok1) and activates NF-kappa B.
Sylla BS; Murphy K; Cahir-McFarland E; Lane WS; Mosialos G; Kieff E
Proc Natl Acad Sci U S A; 2000 Jun; 97(13):7470-5. PubMed ID: 10852966
[TBL] [Abstract][Full Text] [Related]
28. Impaired humoral immunity in X-linked lymphoproliferative disease is associated with defective IL-10 production by CD4+ T cells.
Ma CS; Hare NJ; Nichols KE; Dupré L; Andolfi G; Roncarolo MG; Adelstein S; Hodgkin PD; Tangye SG
J Clin Invest; 2005 Apr; 115(4):1049-59. PubMed ID: 15761493
[TBL] [Abstract][Full Text] [Related]
29. Frequent mutations in SH2D1A (XLP) in males presenting with high-grade mature B-cell neoplasms.
Sandlund JT; Shurtleff SA; Onciu M; Horwitz E; Leung W; Howard V; Rencher R; Conley ME
Pediatr Blood Cancer; 2013 Sep; 60(9):E85-7. PubMed ID: 23589280
[TBL] [Abstract][Full Text] [Related]
30. Structural basis for SH2D1A mutations in X-linked lymphoproliferative disease.
Lappalainen I; Giliani S; Franceschini R; Bonnefoy JY; Duckett C; Notarangelo LD; Vihinen M
Biochem Biophys Res Commun; 2000 Mar; 269(1):124-30. PubMed ID: 10694488
[TBL] [Abstract][Full Text] [Related]
31. Severe XLP Phenotype Caused by a Novel Intronic Mutation in the SH2D1A Gene.
Tóth B; Soltész B; Gyimesi E; Csorba G; Veres Á; Lányi Á; Kovács G; Maródi L; Erdős M
J Clin Immunol; 2015 Jan; 35(1):26-31. PubMed ID: 25491288
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive molecular diagnosis of Epstein-Barr virus-associated lymphoproliferative diseases using next-generation sequencing.
Ono S; Nakayama M; Kanegane H; Hoshino A; Shimodera S; Shibata H; Fujino H; Fujino T; Yunomae Y; Okano T; Yamashita M; Yasumi T; Izawa K; Takagi M; Imai K; Zhang K; Marsh R; Picard C; Latour S; Ohara O; Morio T
Int J Hematol; 2018 Sep; 108(3):319-328. PubMed ID: 29777376
[TBL] [Abstract][Full Text] [Related]
33. A spectrum of mutations in SH2D1A that causes X-linked lymphoproliferative disease and other Epstein-Barr virus-associated illnesses.
Sumegi J; Seemayer TA; Huang D; Davis JR; Morra M; Gross TG; Yin L; Romco G; Klein E; Terhorst C; Lanyi A
Leuk Lymphoma; 2002 Jun; 43(6):1189-201. PubMed ID: 12152986
[TBL] [Abstract][Full Text] [Related]
34. A "three-pronged" binding mechanism for the SAP/SH2D1A SH2 domain: structural basis and relevance to the XLP syndrome.
Hwang PM; Li C; Morra M; Lillywhite J; Muhandiram DR; Gertler F; Terhorst C; Kay LE; Pawson T; Forman-Kay JD; Li SC
EMBO J; 2002 Feb; 21(3):314-23. PubMed ID: 11823424
[TBL] [Abstract][Full Text] [Related]
35. Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency).
Pachlopnik Schmid J; Canioni D; Moshous D; Touzot F; Mahlaoui N; Hauck F; Kanegane H; Lopez-Granados E; Mejstrikova E; Pellier I; Galicier L; Galambrun C; Barlogis V; Bordigoni P; Fourmaintraux A; Hamidou M; Dabadie A; Le Deist F; Haerynck F; Ouachée-Chardin M; Rohrlich P; Stephan JL; Lenoir C; Rigaud S; Lambert N; Milili M; Schiff C; Chapel H; Picard C; de Saint Basile G; Blanche S; Fischer A; Latour S
Blood; 2011 Feb; 117(5):1522-9. PubMed ID: 21119115
[TBL] [Abstract][Full Text] [Related]
36. Differential methylation pattern of the X-linked lymphoproliferative (XLP) disease gene SH2D1A correlates with the cell lineage-specific transcription.
Parolini O; Weinhäusel A; Kagerbauer B; Sassmann J; Holter W; Gadner H; Haas OA; Knapp W
Immunogenetics; 2003 May; 55(2):116-21. PubMed ID: 12709835
[TBL] [Abstract][Full Text] [Related]
37. Potential pathogenic mechanism of type 1 X-linked lymphoproliferative syndrome caused by a mutation of SH2D1A gene in an infant: A case report.
Wang Y; Wang Y; Lu W; Tao L; Xiao Y; Zhou Y; He X; Zhang Y; Li L
Medicine (Baltimore); 2022 Oct; 101(41):e30951. PubMed ID: 36254040
[TBL] [Abstract][Full Text] [Related]
38. Persistent hypogammaglobulinemia following mononucleosis in boys is highly suggestive of X-linked lymphoproliferative disease--report of three cases.
Hügle B; Suchowerskyj P; Hellebrand H; Adler B; Borte M; Sack U; Overberg-Schmidt US; Strnad N; Otto J; Meindl A; Schuster V
J Clin Immunol; 2004 Sep; 24(5):515-22. PubMed ID: 15359110
[TBL] [Abstract][Full Text] [Related]
39. Intronic SH2D1A mutation with impaired SAP expression and agammaglobulinemia.
Recher M; Fried AJ; Massaad MJ; Kim HY; Rizzini M; Frugoni F; Walter JE; Mathew D; Eibel H; Hess C; Giliani S; Umetsu DT; Notarangelo LD; Geha RS
Clin Immunol; 2013 Feb; 146(2):84-9. PubMed ID: 23280491
[TBL] [Abstract][Full Text] [Related]
40. Pathogenesis and diagnosis of X-linked lymphoproliferative disease.
Gilmour KC; Gaspar HB
Expert Rev Mol Diagn; 2003 Sep; 3(5):549-61. PubMed ID: 14510176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
